United Capital Financial Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-24,948
| Closed | -$370K | – | 1041 |
|
|
2022
Q3 | $370K | Buy |
24,948
+11
| +0% | +$163 | ﹤0.01% | 846 |
|
|
2022
Q2 | $393K | Buy |
24,937
+1
| +0% | +$16 | ﹤0.01% | 858 |
|
|
2022
Q1 | $672K | Buy |
24,936
+11
| +0% | +$296 | ﹤0.01% | 765 |
|
|
2021
Q4 | $922K | Buy |
24,925
+5
| +0% | +$185 | ﹤0.01% | 693 |
|
|
2021
Q3 | $1.19M | Hold |
24,920
| – | – | 0.01% | 628 |
|
|
2021
Q2 | $843K | Sell |
24,920
-5
| -0% | -$169 | ﹤0.01% | 733 |
|
|
2021
Q1 | $1.03M | Sell |
24,925
-1,341
| -5% | -$55.4K | 0.01% | 659 |
|
|
2020
Q4 | $1.14M | Sell |
26,266
-2,130
| -8% | -$92.4K | 0.01% | 642 |
|
|
2020
Q3 | $1.22M | Sell |
28,396
-1,204
| -4% | -$51.6K | 0.01% | 601 |
|
|
2020
Q2 | $1.38M | Hold |
29,600
| – | – | 0.01% | 582 |
|
|
2020
Q1 | $402K | Hold |
29,600
| – | – | ﹤0.01% | 885 |
|
|
2019
Q4 | $322K | Hold |
29,600
| – | – | ﹤0.01% | 1104 |
|
|
2019
Q3 | $304K | Buy |
29,600
+2,300
| +8% | +$23.6K | ﹤0.01% | 1063 |
|
|
2019
Q2 | $258K | Hold |
27,300
| – | – | ﹤0.01% | 1254 |
|
|
2019
Q1 | $186K | Hold |
27,300
| – | – | ﹤0.01% | 1261 |
|
|
2018
Q4 | $124K | Hold |
27,300
| – | – | ﹤0.01% | 1234 |
|
|
2018
Q3 | $241K | Hold |
27,300
| – | – | ﹤0.01% | 1194 |
|
|
2018
Q2 | $232K | Buy |
27,300
+12,800
| +88% | +$109K | ﹤0.01% | 1183 |
|
|
2018
Q1 | $80K | Buy |
+14,500
| New | +$80K | ﹤0.01% | 1278 |
|